Q92876 (KLK6_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 120.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Kallikrein-6 EC=3.4.21.- Alternative name(s): Neurosin Protease M SP59 Serine protease 18 Serine protease 9 Zyme | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 244 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Serine protease which exhibits a preference for Arg over Lys in the substrate P1 position and for Ser or Pro in the P2 position. Shows activity against amyloid precursor protein, myelin basic protein, gelatin, casein and extracellular matrix proteins such as fibronectin, laminin, vitronectin and collagen. Degrades alpha-synuclein and prevents its polymerization, indicating that it may be involved in the pathogenesis of Parkinson disease and other synucleinopathies. May be involved in regulation of axon outgrowth following spinal cord injury. Tumor cells treated with a neutralizing KLK6 antibody migrate less than control cells, suggesting a role in invasion and metastasis. Ref.16 Ref.17 Ref.18 Ref.19 Ref.20 Ref.23 |
| Enzyme regulation | Inhibited by a range of serine protease inhibitors including soybean trypsin inhibitor, benzamidine and serpins. Activated by a range of glycosaminoglycans including chondroitin sulfate, dermatan sulfate, heparan sulfate and heparin. Ref.16 Ref.20 |
| Subcellular location | Secreted. Nucleus › nucleolus. Cytoplasm. Mitochondrion. Microsome. Note: In brain, detected in the nucleus of glial cells and in the nucleus and cytoplasm of neurons. Detected in the mitochondrial and microsomal fractions of HEK-293 cells and released into the cytoplasm following cell stress. Ref.13 Ref.14 Ref.17 |
| Tissue specificity | In fluids, highest levels found in milk of lactating women followed by cerebrospinal fluid, nipple aspirate fluid and breast cyst fluid. Also found in serum, seminal plasma and some amniotic fluids and breast tumor cytosolic extracts. Not detected in urine. At the tissue level, highest concentrations found in glandular tissues such as salivary glands followed by lung, colon, fallopian tube, placenta, breast, pituitary and kidney. Not detected in skin, spleen, bone, thyroid, heart, ureter, liver, muscle, endometrium, testis, pancreas, seminal vesicle, ovary, adrenals and prostate. In brain, detected in gray matter neurons (at protein level). Colocalizes with pathological inclusions such as Lewy bodies and glial cytoplasmic inclusions. Overexpressed in primary breast tumors but not expressed in metastatic tumors. Ref.7 Ref.13 Ref.14 Ref.15 Ref.17 |
| Induction | By spinal cord injury. This effect is particularly prominent in macrophages, microglia and reactive astrocytes. Ref.16 Ref.19 Ref.20 |
| Post-translational modification | Inactivated by autolytic cleavage after Arg-80. |
| Sequence similarities | Belongs to the peptidase S1 family. Kallikrein subfamily. Contains 1 peptidase S1 domain. |
| Biophysicochemical properties | Kinetic parameters: KM=1562 µM for Tosyl-Gly-Pro-Arg-AMC Ref.16 Ref.23 KM=777 µM for Tosyl-Gly-Pro-Lys-AMC KM=0.410 mM for Phe-Ser-Arg-AMC KM=0.455 mM for Gly-Gly-Arg-AMC KM=0.335 mM for Asp-Pro-Arg-AMC KM=0.758 mM for Gln-Gly-Arg-AMC KM=0.625 mM for Pro-Phe-Arg-AMC KM=0.271 mM for Val-Pro-Arg-AMC KM=1.72 mM for Val-Leu-Lys-AMC |
| Mass spectrometry | Molecular mass is 25866 Da from positions 22 - 244. Determined by MALDI. Ref.23 |
Ontologies
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q92876-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q92876-2) The sequence of this isoform differs from the canonical sequence as follows: 1-107: Missing. | ||||||
| Isoform 3 (identifier: Q92876-3) The sequence of this isoform differs from the canonical sequence as follows: 14-40: AWAEEQNKLVHGGPCDKTSHPYQAALY → GIFRSSWGSITFGKGRVPRSRVLLSGL 41-244: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 16 | 16 | Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Propeptide | 17 – 21 | 5 | Activation peptide Potential | PRO_0000027940 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 22 – 244 | 223 | Kallikrein-6 | PRO_0000027941 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 22 – 242 | 221 | Peptidase S1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 62 | 1 | Charge relay system Ref.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 106 | 1 | Charge relay system Ref.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 197 | 1 | Charge relay system Ref.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Site | 80 – 81 | 2 | Cleavage; by autolysis | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 134 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 28 ↔ 157 | Ref.22 Ref.23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 47 ↔ 63 | Ref.22 Ref.23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 131 ↔ 231 | Ref.22 Ref.23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 138 ↔ 203 | Ref.22 Ref.23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 168 ↔ 182 | Ref.22 Ref.23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 193 ↔ 218 | Ref.22 Ref.23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 107 | 107 | Missing in isoform 2. | VSP_034403 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 14 – 40 | 27 | AWAEE…QAALY → GIFRSSWGSITFGKGRVPRS RVLLSGL in isoform 3. | VSP_034404 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 41 – 244 | 204 | Missing in isoform 3. | VSP_034405 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 78 | 1 | R → W. Corresponds to variant rs61469141 [ dbSNP | Ensembl ]. | VAR_061776 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 27 – 29 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 36 – 41 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 44 – 53 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 56 – 59 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 61 – 63 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 69 – 73 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 75 – 77 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 85 – 94 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 100 – 102 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 108 – 114 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 137 – 144 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 146 – 149 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 156 – 163 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 165 – 171 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 173 – 175 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 180 – 184 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 186 – 188 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 194 – 198 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 200 – 203 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 206 – 213 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 221 – 223 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 225 – 229 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 230 – 233 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 234 – 237 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A novel protease homolog differentially expressed in breast and ovarian cancer." Anisowicz A., Sotiropoulou G., Stenman G., Mok S.C., Sager R. Mol. Med. 2:624-636(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [2] | "Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain." Yamashiro K., Tsuruoka N., Kodama S., Tsujimoto M., Yamamura Y., Tanaka T., Nakazato H., Yamaguchi N. Biochim. Biophys. Acta 1350:11-14(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Colon. |
| [3] | "Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain." Little S.P., Dixon E.P., Norris F., Buckley W., Becker G.W., Johnson M., Dobbins J.R., Wyrick T., Miller J.R., Mackellar W., Hepburn D., Corvalan J., McClure D., Liu X., Stephenson D., Clemens J., Johnstone E.M. J. Biol. Chem. 272:25135-25142(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Brain. |
| [4] | "Molecular characterization of Zyme/protease M/neurosin(PRSS9), a hormonally regulated kallikrein-like serine protease." Yousef G.M., Luo L.Y., Scherer S.W., Sotiropoulou G., Diamandis E.P. Genomics 62:251-259(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [5] | "Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region." Gan L., Lee I., Smith R., Argonza-Barrett R., Lei H., McCuaig J., Moss P., Paeper B., Wang K. Gene 257:119-130(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [6] | "Cloning and characterization of novel isoforms of the human kallikrein 6 gene." Pampalakis G., Kurlender L., Diamandis E.P., Sotiropoulou G. Biochem. Biophys. Res. Commun. 320:54-61(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3). Tissue: Testis. |
| [7] | "Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer." Pampalakis G., Sotiropoulou G. Biol. Chem. 387:773-782(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY. |
| [8] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [9] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [10] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [11] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [12] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Colon. |
| [13] | "Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications." Diamandis E.P., Yousef G.M., Soosaipillai A.R., Grass L., Porter A., Little S., Sotiropoulou G. Clin. Biochem. 33:369-375(2000) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [14] | "Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease." Ogawa K., Yamada T., Tsujioka Y., Taguchi J., Takahashi M., Tsuboi Y., Fujino Y., Nakajima M., Yamamoto T., Akatsu H., Mitsui S., Yamaguchi N. Psychiatry Clin. Neurosci. 54:419-426(2000) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [15] | "The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry." Petraki C.D., Karavana V.N., Skoufogiannis P.T., Little S.P., Howarth D.J.C., Yousef G.M., Diamandis E.P. J. Histochem. Cytochem. 49:1431-1441(2001) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [16] | "Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors." Magklara A., Mellati A.A., Wasney G.A., Little S.P., Sotiropoulou G., Becker G.W., Diamandis E.P. Biochem. Biophys. Res. Commun. 307:948-955(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AUTOCATALYTIC CLEAVAGE. |
| [17] | "Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies." Iwata A., Maruyama M., Akagi T., Hashikawa T., Kanazawa I., Tsuji S., Nukina N. Hum. Mol. Genet. 12:2625-2635(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [18] | "Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells." Ghosh M.C., Grass L., Soosaipillai A., Sotiropoulou G., Diamandis E.P. Tumor Biol. 25:193-199(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [19] | "Dynamic role of kallikrein 6 in traumatic spinal cord injury." Scarisbrick I.A., Sabharwal P., Cruz H., Larsen N., Vandell A.G., Blaber S.I., Ameenuddin S., Papke L.M., Fehlings M.G., Reeves R.K., Blaber M., Windebank A.J., Rodriguez M. Eur. J. Neurosci. 24:1457-1469(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INDUCTION. |
| [20] | "Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects." Angelo P.F., Lima A.R., Alves F.M., Blaber S.I., Scarisbrick I.A., Blaber M., Juliano L., Juliano M.A. J. Biol. Chem. 281:3116-3126(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ENZYME REGULATION. |
| [21] | "The autolytic regulation of human kallikrein-related peptidase 6." Blaber S.I., Yoon H., Scarisbrick I.A., Juliano M.A., Blaber M. Biochemistry 46:5209-5217(2007) [PubMed] [Europe PMC] [Abstract] Cited for: AUTOCATALYTIC CLEAVAGE. |
| [22] | "The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family." Gomis-Rueth F.X., Bayes A., Sotiropoulou G., Pampalakis G., Tsetsenis T., Villegas V., Aviles F.X., Coll M. J. Biol. Chem. 277:27273-27281(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 21-243, AUTOCATALYTIC CLEAVAGE, ACTIVE SITES, DISULFIDE BONDS. |
| [23] | "Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system." Bernett M.J., Blaber S.I., Scarisbrick I.A., Dhanarajan P., Thompson S.M., Blaber M. J. Biol. Chem. 277:24562-24570(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 22-244, PROTEIN SEQUENCE OF 22-25, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AUTOCATALYTIC CLEAVAGE, DISULFIDE BONDS, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U62801 mRNA. Translation: AAB07113.1. D78203 mRNA. Translation: BAA11306.1. AF013988 mRNA. Translation: AAB66483.1. AF149289 Genomic DNA. Translation: AAD51475.1. AF243527 Genomic DNA. Translation: AAG33359.1. AY318867 mRNA. Translation: AAP82446.1. AY318868 mRNA. No translation available. AY318869 mRNA. Translation: AAP82448.1. AY318870 mRNA. No translation available. DQ223012 mRNA. Translation: ABB04464.1. AK314897 mRNA. Translation: BAG37411.1. BT006852 mRNA. Translation: AAP35498.1. AC011483 Genomic DNA. No translation available. CH471135 Genomic DNA. Translation: EAW71953.1. CH471135 Genomic DNA. Translation: EAW71954.1. BC015525 mRNA. Translation: AAH15525.1. | ||||||||||||||||||||||||||||||||||||
| IPI | IPI00023845. IPI00554738. IPI00896372. | ||||||||||||||||||||||||||||||||||||
| RefSeq | NP_001012982.1. NM_001012964.1. NP_001012983.1. NM_001012965.1. NP_002765.1. NM_002774.3. | ||||||||||||||||||||||||||||||||||||
| UniGene | Hs.79361. | ||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | Q92876. | ||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||
| IntAct | Q92876. 12 interactions. | ||||||||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000309148. | ||||||||||||||||||||||||||||||||||||
Protein family/group databases | |||||||||||||||||||||||||||||||||||||
| MEROPS | S01.236. | ||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||
| PhosphoSite | Q92876. | ||||||||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||||||||
| DMDM | 3914480. | ||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||
| PaxDb | Q92876. | ||||||||||||||||||||||||||||||||||||
| PeptideAtlas | Q92876. | ||||||||||||||||||||||||||||||||||||
| PRIDE | Q92876. | ||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||
| DNASU | 5653. | ||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000310157; ENSP00000309148; ENSG00000167755. ENST00000376851; ENSP00000366047; ENSG00000167755. ENST00000391808; ENSP00000375684; ENSG00000167755. ENST00000424910; ENSP00000396012; ENSG00000167755. ENST00000456750; ENSP00000409241; ENSG00000167755. ENST00000594641; ENSP00000470482; ENSG00000167755. ENST00000597379; ENSP00000469630; ENSG00000167755. ENST00000599881; ENSP00000471948; ENSG00000167755. | ||||||||||||||||||||||||||||||||||||
| GeneID | 5653. | ||||||||||||||||||||||||||||||||||||
| KEGG | hsa:5653. | ||||||||||||||||||||||||||||||||||||
| UCSC | uc002puh.3. human. | ||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||
| CTD | 5653. | ||||||||||||||||||||||||||||||||||||
| GeneCards | GC19M051461. | ||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:6367. KLK6. | ||||||||||||||||||||||||||||||||||||
| MIM | 602652. gene. | ||||||||||||||||||||||||||||||||||||
| neXtProt | NX_Q92876. | ||||||||||||||||||||||||||||||||||||
| PharmGKB | PA30156. | ||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||
| eggNOG | COG5640. | ||||||||||||||||||||||||||||||||||||
| HOGENOM | HOG000251820. | ||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG013304. | ||||||||||||||||||||||||||||||||||||
| InParanoid | Q92876. | ||||||||||||||||||||||||||||||||||||
| KO | K08667. | ||||||||||||||||||||||||||||||||||||
| OMA | CAGDEKY. | ||||||||||||||||||||||||||||||||||||
| PhylomeDB | Q92876. | ||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | alphasynuclein_pathway. Alpha-synuclein signaling. | ||||||||||||||||||||||||||||||||||||
| SABIO-RK | Q92876. | ||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||
| ArrayExpress | Q92876. | ||||||||||||||||||||||||||||||||||||
| Bgee | Q92876. | ||||||||||||||||||||||||||||||||||||
| CleanEx | HS_KLK6. | ||||||||||||||||||||||||||||||||||||
| Genevestigator | Q92876. | ||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000167755. Homo sapiens. | ||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||
| InterPro | IPR001254. Peptidase_S1. IPR018114. Peptidase_S1_AS. IPR001314. Peptidase_S1A. IPR009003. Trypsin-like_Pept_dom. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| Pfam | PF00089. Trypsin. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| PRINTS | PR00722. CHYMOTRYPSIN. | ||||||||||||||||||||||||||||||||||||
| SMART | SM00020. Tryp_SPc. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| SUPFAM | SSF50494. Pept_Ser_Cys. 1 hit. | ||||||||||||||||||||||||||||||||||||
| PROSITE | PS50240. TRYPSIN_DOM. 1 hit. PS00134. TRYPSIN_HIS. 1 hit. PS00135. TRYPSIN_SER. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||
| BindingDB | Q92876. | ||||||||||||||||||||||||||||||||||||
| ChEMBL | CHEMBL4448. | ||||||||||||||||||||||||||||||||||||
| EvolutionaryTrace | Q92876. | ||||||||||||||||||||||||||||||||||||
| GenomeRNAi | 5653. | ||||||||||||||||||||||||||||||||||||
| NextBio | 21966. | ||||||||||||||||||||||||||||||||||||
| PMAP-CutDB | Q92876. | ||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | KLK6_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q92876 Secondary accession number(s): A6NJA1, A8MW09, Q6H301 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
